Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Protagonist Therapeutics, Inc.

PTGX Technical Analysis Summary (NASDAQ)

Analyze PTGX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

PTGX●NASDAQ
HealthcareBiotechnology
$136.96
$4.68(3.54%)
U.S. Market is Open · 14:25

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

PTGX Technical Analysis Summary (NASDAQ)

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.

Overall Sentiment:Buy
Momentum:Neutral to Bullish (RSI: 57.61)
Trend Strength:Strong (ADX: 35.87)
Volatility:Medium (ATR: 5.92)
Support/Resistance:$129.50 – $141.39 (Bollinger Bands)

Technical conditions suggest Protagonist Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest Protagonist Therapeutics, Inc. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 57.61

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 49.03

Neutral
Mid-range signal with no clear trend.

Williams %R: -44.71

Neutral
Balanced market without strong signals.

Rate of Change (ROC): 1.60

Bullish
Steady upward momentum.

Takeaway:Protagonist Therapeutics, Inc. shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: 3.76

Bullish
Bullish, trend momentum is strengthening.

ADX: 35.87

Strong
Strong trend, momentum well established.

ATR (14): 5.92

High
High volatility, wide price fluctuations.

CCI (14): 24.01

Bullish
Bullish, momentum building upward.

Takeaway:Protagonist Therapeutics, Inc. shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators
Bollinger Bands
Upper Band
$141.39
Middle Band (SMA 20)
$135.44
Lower Band
$129.50
Current Position
Within Bands

Takeaway:Protagonist Therapeutics, Inc. trades closer to resistance, supported by stronger momentum within bands.

Keltner Channels
Upper Channel
$145.34
Middle Line (EMA 20)
$133.50
Lower Channel
$121.66
Squeeze Status
Squeeze On

Takeaway:Protagonist Therapeutics, Inc. trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume-49.65K
Money Flow Index39.42Bearish, selling pressure outweighs inflows.
Relative Vigor Index45.80Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:PTGX shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of Protagonist Therapeutics, Inc. (NASDAQ: PTGX), here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for Protagonist Therapeutics, Inc. are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: PTGX) Technical Analysis FAQ